Cardax Inc (CDXI):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cardax Inc (CDXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7980
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cardax Inc (Cardax), formerly Cardax Pharmaceuticals Inc is a life science company that discovers and develops pharmaceutical and consumer health technologies. The company discovers and develops anti-inflammatory dietary supplements, small molecule therapies, medicinal products, and drug products. Its astaxanthin is a small molecule compound found in marine organisms that includes microalgae, salmon and trout, and crustaceans, among others. Cardax’s product reduces the inflammation of many anti-inflammatory products. The company’s products address the market segments such as metabolic syndrome, osteoarthritis, cognitive decline, hepatic disease, triglycerides, diabetes, atherosclerosis and thrombosis, among others. It also provides scientific data to physicians and patient groups. Cardax is headquartered in Honolulu, Hawaii, the US.

Cardax Inc (CDXI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Cardax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cardax Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cardax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cardax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Cardax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cardax Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Cardax Pharma Raises US$2 Million In Venture Financing 11
Cardax Pharma Raises US$0.8 Million In Venture Financing 12
Partnerships 13
Capsugel Enter into Co-Development Agreement with Cardax for Astaxanthin Products 13
Merger 14
Koffee Korner Merges with Cardax Pharma 14
Licensing Agreements 15
Biomiga Diagnostics Enters into Licensing Agreement with Cardax 15
Equity Offering 16
Cardax Raises USD1.2 Million in Public Offering of Shares 16
Cardax Pharma Raises USD0.05 Million in Private Placement of Shares 17
Cardax Raises Funds in Private Placement of Shares 18
Cardax Raises USD0.5 Million in Financing 19
Cardax Raises Additional USD0.5 Million in Financing 20
Cardax Pharma Raises USD4 Million in Private Placement 21
Cardax Pharma Raises USD2 Million in Private Placement 22
Cardax Pharma Raises USD5 Million in Private Placement 23
Debt Offering 24
Cardax Pharma Raises USD2 Million in Public Offering of 10% Notes 24
Cardax Inc – Key Competitors 25
Cardax Inc – Key Employees 26
Cardax Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Aug 13, 2018: Cardax reports Q2 2018 results 28
Mar 27, 2018: Cardax Reports 2017 Results 29
Nov 14, 2017: Cardax Reports Q3 2017 Results 30
Aug 11, 2017: Cardax Reports Q2 2017 Results 31
May 15, 2017: Cardax Q1 2017 Revenues Triple vs. Prior Two Quarters Combined 32
Corporate Communications 33
Jun 01, 2018: Cardax Adds Makarand Jawadekar, Ph.D., and Elona Kogan to its Board of Directors 33
Sep 07, 2017: Cardax Promotes David M. Watumull to COO; Partially Restores Compensation Company-Wide 34
Jan 10, 2017: Cardax Appoints Global Healthcare Executive as Independent Director 35
Product News 36
Oct 04, 2018: Cardax doses first patient in CHASE trial for cardiovascular health drug 36
Sep 19, 2017: Cardax Welcomes Cardiovascular Research Breakthrough 37
Jun 13, 2018: Cardax Engages Industry Veteran Fred Sancilio, Ph.D., to Launch Orphan Drug Development Program 38
Jan 25, 2017: Cardax Announces Launch of ZanthoSyn in Hawaii GNC Stores 39
Other Significant Developments 40
Feb 17, 2018: Cardax’s ZanthoSyn is No. 1 Seller at GNC Hawaii Stores 40
Feb 17, 2018: Cardax Inks Deal to Distribute ZanthoSyn in China 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Cardax Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Cardax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cardax Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cardax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cardax Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Cardax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cardax Pharma Raises US$2 Million In Venture Financing 11
Cardax Pharma Raises US$0.8 Million In Venture Financing 12
Capsugel Enter into Co-Development Agreement with Cardax for Astaxanthin Products 13
Koffee Korner Merges with Cardax Pharma 14
Biomiga Diagnostics Enters into Licensing Agreement with Cardax 15
Cardax Raises USD1.2 Million in Public Offering of Shares 16
Cardax Pharma Raises USD0.05 Million in Private Placement of Shares 17
Cardax Raises Funds in Private Placement of Shares 18
Cardax Raises USD0.5 Million in Financing 19
Cardax Raises Additional USD0.5 Million in Financing 20
Cardax Pharma Raises USD4 Million in Private Placement 21
Cardax Pharma Raises USD2 Million in Private Placement 22
Cardax Pharma Raises USD5 Million in Private Placement 23
Cardax Pharma Raises USD2 Million in Public Offering of 10% Notes 24
Cardax Inc, Key Competitors 25
Cardax Inc, Key Employees 26
Cardax Inc, Subsidiaries 27

List of Figures
Cardax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cardax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cardax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cardax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cardax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cardax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Cardax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cardax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[Cardax Inc (CDXI):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Societe Des Bains De Mer Sa
    Societe Des Bains De Mer Sa - Strategy, SWOT and Corporate Finance Report Summary Societe Des Bains De Mer Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Celanese Corporation:企業の戦略・SWOT・財務情報
    Celanese Corporation - Strategy, SWOT and Corporate Finance Report Summary Celanese Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Aspen Technology Inc (AZPN):企業の財務・戦略的SWOT分析
    Aspen Technology Inc (AZPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Linde Malaysia Sdn Bhd:企業の戦略的SWOT分析
    Linde Malaysia Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Fuji Seal International Inc.:戦略・SWOT・企業財務分析
    Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report Summary Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Essel Propack Limited:企業の戦略・SWOT・財務情報
    Essel Propack Limited - Strategy, SWOT and Corporate Finance Report Summary Essel Propack Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • WCCT Global Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary WCCT Global Inc (WCCT Global) is a contract research organization that offers early drug development and late phase CRO services. The organization provides CRO solutions, clinical development and clinical support services. Its CRO solutions include project management, clinical monitoring, ph …
  • Enbridge Inc (ENB):石油・ガス:M&Aディール及び事業提携情報
    Summary Enbridge Inc (Enbridge) is an integrated energy company. It carries out natural gas gathering, processing, transmission and distribution; transportation of crude oil; and marketing of petroleum products. The company also involved in power generation and transmission and has interests in rene …
  • Exelon Corporation:企業の戦略・SWOT・財務情報
    Exelon Corporation - Strategy, SWOT and Corporate Finance Report Summary Exelon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nuvaira Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nuvaira Inc (Nuvaira), formerly Holaira Inc is an independent medical device company that strives to develop minimally invasive products for the treatment of obstructive lung diseases. It provides Lung Denervation System, a catheter-based system intended for asthma and chronic obstructive pu …
  • Mincor Resources NL:企業の戦略・SWOT・財務情報
    Mincor Resources NL - Strategy, SWOT and Corporate Finance Report Summary Mincor Resources NL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ExamWorks Group Inc:企業のM&A・事業提携・投資動向
    ExamWorks Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ExamWorks Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • AorTech International Plc (AOR):医療機器:M&Aディール及び事業提携情報
    Summary AorTech International plc (AorTech) is an Intellectual Property (IP) holding company. It develops and commercializes biologically stable polymers for next generation medical devices. It provides a broad range of polyurethane technologies for applications in cardiovascular surgery, interventi …
  • Trust International Insurance Co. P.L.C.
    Trust International Insurance Co. P.L.C. - Strategy, SWOT and Corporate Finance Report Summary Trust International Insurance Co. P.L.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • International Finance Corp:企業の戦略的SWOT分析
    International Finance Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • PTT Exploration and Production Public Co Ltd (PTTEP):石油・ガス:M&Aディール及び事業提携情報
    Summary PTT Exploration and Production Public Company Limited (PTTEP), a subsidiary of PTT Public Company Limited, is an oil and gas company. It carries out exploration, development and production of hydrocarbons. The company manages an array of exploration projects in different stages and producing …
  • Britannia Industries Ltd (BRITANNIA):企業の財務・戦略的SWOT分析
    Britannia Industries Ltd (BRITANNIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Emcure Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • RealPage, Inc.:企業のM&A・事業提携・投資動向
    RealPage, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RealPage, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆